Search for: "BRISTOL-MYERS SQUIBB" Results 461 - 480 of 863
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
31 Jan 2013, 2:39 pm by Prashant Reddy
Earlier in February, 2006 Emcure entered into a similar deal with Bristol Myers Squibbs (BMS) for the manufacture of atanzanavir. [read post]
30 Jan 2013, 1:47 pm by Bexis
Bristol-Myers Squibb Co., 2012 WL 3074538, at *2 (N.D. [read post]
25 Jan 2013, 11:48 am by Lawrence B. Ebert
Bristol-Myers Squibb Co., 938 F.2d 1544, 1549 (2d Cir. 1991)). [read post]
24 Jan 2013, 11:49 am by Bexis
Bristol-Myers Squibb Co., No. 06-6050 (FLW) (D.N.J. [read post]
11 Jan 2013, 6:27 pm by Prashant Reddy
The patents for the remaining two drugs – Ixabepilone and Dastinib are owned by Bristol Myers Squibbs (BMS). [read post]
25 Nov 2012, 1:00 pm
Under  Bristol-Myers Squibb v Paranova condition ("the BMS conditions"), Condition 5 requires the importer to give notice to the trade mark owner before any repackaged product is put on sale, and, on demand, supplies him with a specimen. [read post]
15 Oct 2012, 1:24 am by Kevin LaCroix
It is not even the largest securities suit settlement, having been exceeded, among others, by Bristol Myers Squibb’s $300 million securities lawsuit settlement (about which refer here). [read post]
4 Sep 2012, 1:45 pm by Rodney Mesriani
Experts further expected that the new drug will generate more sales to its manufacturer since its competing experimental drug from Bristol-Myers Squibb. [read post]
4 Sep 2012, 7:31 am by arester
Skadden, Arps, Slate, Meagher & Flom LLP was hired by Amylin to perform delicate corporate surgery, first extracting the diabetes-drug developer—along with, Bydureon, its most valuable drug—from a soured pact with Eli Lilly & Co. and then helping to sell the company to Bristol-Myers Squibb Co. in a $5.1 billion deal that closed in August... [read post]
22 Aug 2012, 7:51 am by arester
Bristol-Myers Squibb Co., resulting in $515 million settlement arising from unlawful conduct including off-label promotion to induce government purchases of the antipsychotic drug Abilify; and United States ex rel. [read post]
22 Aug 2012, 6:09 am
Drug companies including Pfizer, Merck & Co. and Bristol Myers-Squibb Co. are squeezed by rising research costs, the weak global economy and pressure from Europe, China and elsewhere to reduce drug prices. [read post]
17 Aug 2012, 5:35 am by admin
As a high-level executive in the treasury department at Bristol-Myers Squibb, Robert D. [read post]
7 Aug 2012, 10:06 am by The Docket Navigator
Bristol-Myers Squibb Company, 1-12-cv-00394 (DED August 3, 2012, Order) (MDL Panel). [read post]
7 Aug 2012, 8:10 am by Robert J. Tannous
On August 2, 2012, the Securities and Exchanges Commission ("SEC") charged an executive in the treasury department at Bristol-Myers Squibb with insider trading. [read post]